ImmunityBio leverages a persistent BCG shortage and expanding Anktiva use in NMIBC, with 2026 catalysts including FDA talks, global launches and new clinical milestones.

Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, "Charter") today announced that Jessica Fischer, Chief Financial Officer, will participate in the NSR and BCG Global ...

ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...

The BCG strain Tokyo-172 is noninferior to the commonly used TICE strain for relapse-free survival, which could help to alleviate BCG shortages.

Perplexity Personal Computer software can turn a Mac mini into a personal AI project manager. But should you give it access ...

The MarketWatch News Department was not involved in the creation of this content. -- Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional ...

Part of the pitch for using AI at work goes like this: It’s like having a team of people to delegate your grunt work to, ...

The Bar Council of India (BCI) has issued a stern common show-cause notice to 12 candidates and two individuals following allegations of grave misconduct during the Bar Council of Gujarat (BCG) ...

Combat Medical (Combat), a medical device company optimising the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first close of a Series A financing to ...

McKinsey & Company, long regarded as the "epitome of consulting" and a guiding force in corporate strategy for global enterprises, is facing its greatest crisis as it marks its 100th anniversary.